BioMarin announces Phase III study of GALNS for MPS IV meets primary endpoint

BioMarin announces Phase III study of GALNS for MPS IV meets primary endpoint”

FLYER (pdf)

This entry was posted in News and tagged . Bookmark the permalink.

Comments are closed.